Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
L. Heim (Erlangen, Germany). The role of STAT3 in T-cell responses during the development of NSCLC. 4205

Member's Comments

No comment yet.

Related content which might interest you: The role of NFATc1 in T cell responses during the development of NSCLC Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 The expression of PD-L1 on the lung cancer cell and its role in T cell anergy Source: Eur Respir J 2007; 30: Suppl. 51, 289s Year: 2007 Depletion of STAT6 suppresses lung cancer progression through regulating M2-macrophage polarization Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 KPNB1-mediated PD-L1 nuclear translocation promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signalling pathway Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 The role of CD40 molecule in human lung cancer and its application in immunotherapy Source: Eur Respir J 2003; 22: Suppl. 45, 199s Year: 2003 Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses tumor-specific T cell immunity Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 c-Met expression induction in immune cells modulates pulmonary fibrosis progression Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Specific plasmids encoding shRNA molecules directed against growth factor receptors in cell proliferation inhibition and induction phenotype changes relevant to enhancement of anti-tumor immunity. Model of human non-small (NSCLC) and small (SCLC) cell lung cancer lines Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 Interleukin-17 enhances the net angiogenic potential and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis Source: Eur Respir J 2004; 24: Suppl. 48, 79s Year: 2004 EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020 NTHi-induced inflammation activates the PD-1 immune checkpoint in the tumor microenvironment Source: International Congress 2018 – Lung cancer: novel molecular markers and mechanisms Year: 2018 GATA-3 phosphorylation by p38 MAP kinase plays a critical role in regulating Th2 cytokine gene expression Source: Eur Respir J 2003; 22: Suppl. 45, 386s Year: 2003 CDCA promotes non-small-cell lung cancer (NSCLC) migration by regulating Akt/Erk1/2 signaling pathways Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology Year: 2019 NTHi-promoted proliferation of K-ras-induced early lung cancer lesions is fully dependent on Toll-like receptor signaling Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 Inhibition of osteopontin modulates tumor-stimulated immune response and suppresses mesothelioma progression Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 P2X7 receptor regulates cell survival, inflammation processes and proliferation of lung carcinoma cells Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019 Cytotoxic T cell antigen 4 and the status of T cell activation in lung cancer: local vs. systemic immune response. Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017 T-cell susceptibility to glucocorticoid (GC)-induced apoptosis: the role in asthma pathogenesis and therapy Source: Eur Respir J 2006; 28: Suppl. 50, 227s Year: 2006 GSK-3 inhibition suppresses lung cancer cell survival, metastasis and proliferation through down-regulation the phosphorylation sites of CAP1 Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 CSE exposure abrogates regulatory effects of the bronchial epithelium on B cell survival and IgA production in a coculture system. A pivotal role of TACI Source: Annual Congress 2012 - Cell culture and animal models of lung disease Year: 2012